SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD

• Published in: PloS one 2024-05, Vol.19 (5), p.e0301807-e0301807
• Main Authors: Ganbold, Chimedlkhamsuren, Jamiyansuren, Jambaldorj, Munkhzorig, Enkhbileg, Dashtseren, Ichinnorov, Jav, Sarantuya
• Format: Article
• Language: English
• Subjects: Aged; Analysis; Biology and Life Sciences; Body mass index; Care and treatment; Case-Control Studies; Chronic obstructive pulmonary disease; Development and progression; Diagnosis; Drug dependence; Enzymes; Experimental research; Female; Gelatinase A; Gelatinase B; Gene polymorphism; Genes; Genetic aspects; Genetic polymorphisms; Genetic Predisposition to Disease; Genotype; Genotypes; Genotyping; Health aspects; Humans; Inflammation; Lung diseases; Lung diseases, Obstructive; Male; Matrix Metalloproteinase 12 - genetics; Matrix Metalloproteinase 2 - genetics; Medicine and Health Sciences; Middle Aged; Oxidative stress; Pathogenesis; Physical Sciences; Physiology; Polymerase chain reaction; Polymorphism; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive - genetics; Questionnaires; Regression analysis; Research and Analysis Methods; Restriction fragment length polymorphism; Risk; Risk Factors; Single nucleotide polymorphisms; Single-nucleotide polymorphism; Smoking; Smoking - adverse effects; Social Sciences; Sociodemographics; Spirometry
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0301807

Determining SNP-SNP interaction of the disease has become important for further investigation of pathogenesis and experimental research. Although many studies have been published on the effect of MMPs gene polymorphisms on chronic obstructive pulmonary disease (COPD), there is a lack of information on SNP-SNP and SNP-environment interactions. This study aimed to investigate the interaction between the polymorphisms of MMP1, MMP2, MMP9 and MMP12 genes and its combined effect with smoking on the risk of developing COPD. Totally 181 COPD patients and 292 healthy individuals were involved. Blood samples from the participants were tested for genotyping and data were collected through questionnaires. Genotyping was performed with nested allele-specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). SNP-SNP and SNP-environment interactions were investigated using multifactor dimensionality reduction and logistic regression analysis. The result showed that participants with high nicotine dependence and heavy smokers had a higher risk of COPD than non-smokers. Also, G/G genotype (cOR = 5.83; 95% CI, 1.19-28.4, p = 0.029) of MMP2 rs243864 and T/T genotype (cOR = 1.79; 95% CI, 1.16-2.76, p = 0.008) of MMP12 rs652438 independently contributes to the susceptibility of COPD. For SNP-SNP interaction, the positive interaction between rs243864 G/G genotype of MMP2 and rs652438 T/T genotype of MMP12 was found, and the combination of risk genotypes has a high risk of COPD (OR = 12.92; 95% CI, 1.46-114.4, p = 0.021). Moreover, the combination of T/T genotype of MMP12 rs652438 and smoking-related factors increases the risk of COPD approximately 4.5 to 6-fold. The results suggests that there is a combination of MMP2, MMP12, and smoking-related factors may increase the risk of developing COPD.